Sinopec and BASF Mutually Recognize Product Carbon Footprint Accounting Methods, Sets New Benchmark for Industry Standardization
NINGBO, China, Oct. 31, 2025 /PRNewswire/ -- China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec") and BASF jointly declared the alignment on the core requirements of carbon footprint accounting methods and reached framework-based mutual...
Bio Farma Indonesia Leads Global Vaccine Manufacturers as Host of the 26th DCVMN AGM in Bali
BALI, Indonesia, Oct. 31, 2025 /PRNewswire/ -- Bali, October 29, 2025, Indonesia, through Bio Farma, is hosting the 26th Annual General Meeting (AGM) of the Developing Countries Vaccine Manufacturers Network (DCVMN) in Bali on October 29–31, 2025....
Elevaris Medical Devices Names New Chief Engineering and Operations Officer
BOSTON, Oct. 31, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization for industry-leading multi-national healthcare companies, announced the appointment of its new Chief Engineering and Operations...
SilentSwap V2 Launch Sets New Standard for Institutional Blockchain Privacy Infrastructure
SilentSwap V2 introduces a privacy-focused infrastructure designed for organizations deploying blockchain technology. Recognizing that over 70% of institutions cite privacy as a major barrier to adoption, SilentSwap V2 addresses transparency risks...
AI Semiconductor Innovator DEEPX Recognized by NYSE and WEF
The Leading Player in On-Device AI Is Realizing the Physical AI Era While Drawing Wall Street's Attention NEW YORK, Oct. 31, 2025 /PRNewswire/ -- As AI begins to sustainably generate tangible value, global AI semiconductor innovator DEEPX (CEO...
Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer
– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naive patients with differentiated thyroid cancer – TOKYO, Oct. 31, 2025 /PRNewswire/ -- Alpha Fusion Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Sunao Fujioka;...
Kexing Biopharm Showcases Global Strategy and Partnership Opportunities at CPHI Frankfurt 2025
FRANKFURT, Germany, Oct. 31, 2025 /PRNewswire/ -- From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, one of the world's most influential pharmaceutical exhibitions, presenting its key product portfolio and international...
Cboe Global Markets Reports Results for Third Quarter 2025 and Announces Strategic Realignment of Business Portfolio
Third Quarter Highlights* Record Diluted EPS for the Quarter of $2.85, Up 38 percent Record Adjusted Diluted EPS¹ for the Quarter of $2.67, Up 20 percent Record Net Revenue for the Quarter of $605.5 million, Up 14 percent Increases 2025 Organic...